❌

Reading view

Structured light–matter interaction in semiconductor cavity quantum electrodynamics

Nature Nanotechnology, Published online: 08 September 2026; doi:10.1038/s41565-026-02275-1

Structured light–matter interaction at the single-photon level is demonstrated in a coupled quantum-dot–micropillar system, enabling cavity-enhanced single-photon emission with spin-locked orbital angular momentum and tunable spin–orbit entanglement.
  •  

Multi-Agent Agentic Graph Learning via Structural Signatures

arXiv:2609.09565v1 Announce Type: new Abstract: Agentic graph learning (AGL) has recently achieved promising results on graph reasoning tasks, where an agent powered by a large language model (LLM) sequentially samples the graph as evidence to support its final prediction. Existing methods either employ a single agent or orchestrate multiple role-based agents to reason and learn over the entire graph, but both essentially rely on a shared reasoning policy across different graph regions, which can be suboptimal for graphs with heterogeneous structural and semantic patterns. Inspired by the progress of multi-agent collaboration on complex reasoning tasks, a natural remedy is to let multiple agents own different memory and collaborate; however, applying this paradigm to graphs directly faces two challenges. First, existing AGL methods typically verbalize graph structures into natural-language descriptions for LLM agents, making the reasoning process sensitive to the ordering of structural information and thereby breaking the permutation-invariant nature of graphs. Second, incorporating increasingly large sampled neighborhoods leads to rapidly growing contexts. To address these challenges, this paper introduces a multi-agent agentic graph learning (i.e., MAAGL) framework. MAAGL partitions the graph into communities and assigns an independent agent to each community for region-specific specialization. MAAGL represents structural and semantic evidence separately. Structural evidence is summarized by a dynamically updated structural signature that is permutation-invariant and fixed in size, while semantic evidence is filtered to the top-k nodes ranked by relevance. Based on historical trajectories with similar signatures, agents estimate their confidence and trigger debate-style collaboration when needed. Extensive experiments on four benchmark datasets show that MAAGL outperforms SOTA AGL methods.
  •  

Artificial intelligence in respiratory medicine: From diagnosis to treatment and future directions

Chin Med J Pulm Crit Care Med. 2026 Jun 6;4(2):99-116. doi: 10.1016/j.pccm.2026.05.005. eCollection 2026 Jun.

ABSTRACT

Lung diseases-including lung cancer, chronic obstructive pulmonary disease (COPD), asthma, interstitial lung diseases (ILDs), and rare conditions like cystic fibrosis-remain major drivers of global morbidity and mortality. Timely diagnosis and individualized treatment are frequently challenged by heterogeneous clinical phenotypes and the complexity of multimodal data. This review provides a critical synthesis of the transformative role of artificial intelligence (AI) in respiratory care, tracing the paradigm shift from classical machine learning to emerging large language models (LLMs) and multimodal foundation models. We evaluate the performance of AI across the patient care continuum: beginning with radiologist-level nodule detection and automated diagnostics, advancing into AI-powered clinical decision support systems (CDSS) and surgical/radiotherapeutic interventions, and culminating in prognostic modeling and "digital twin" simulations for longitudinal patient management. Furthermore, we explore the translational frontier of precision medicine, examining how AI leverages multi-omics and liquid biopsies to drive novel biomarker discovery and accelerate drug repurposing. Finally, we address persistent sociotechnical barriers-including data sovereignty, legal liability, and the critical need for prospective clinical validation-proposing a translational roadmap for the safe integration of generalist medical AI into clinical workflows.

PMID:42396189 | PMC:PMC13323542 | DOI:10.1016/j.pccm.2026.05.005

  •  
❌